Saturday, April 19, 2025
HomePharma

Pharma

Pharma

Lantern Pharma Receives Pre-IND Feedback from the FDA, Clearing a Path for Drug Candidate LP-184’s Phase 1 Clinical Trial in Q2 2023

Life Sciences Times - 0
Pharma

Results of the First Post-Commercial Utilization Review of JELMYTO® Provide New Evidence that Reinforces its Efficacy and Safety in Patients with Low-Grade Upper Tract...

Life Sciences Times - 0
Pharma

Neurotech Pharmaceuticals, Inc. Expands Executive Team with the Appointment of Scott Hunter as Chief Commercial Officer

Life Sciences Times - 0
Pharma

Rocket Pharmaceuticals Expands Cardiac Gene Therapy Portfolio with Addition of RP-A601 for PKP2-ACM and Announces Positive Updated Phase 1 Data for RP-A501 in Danon...

Life Sciences Times - 0
Pharma

HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603

Life Sciences Times - 0
Pharma

Myrtelle Announces Positive Interim Data in Phase 1/2 Clinical Trial of Its Proprietary Investigational Gene Therapy rAAV-Olig001-ASPA in Canavan Disease

Life Sciences Times - 0
Pharma

Glycomine Announces First Patient Dosed in Phase 2 Clinical Study of GLM101, a Potential Treatment for PMM2-CDG

Life Sciences Times - 0
Pharma

Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1

Life Sciences Times - 0
Pharma

FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in Mantle Cell Lymphoma

Life Sciences Times - 0
Pharma

PharmaEssentia Establishes a New Research and Development Facility in the Boston Area

Life Sciences Times - 0
Pharma

Biocytogen and Hansoh Pharma Announce an Antibody License Agreement

Life Sciences Times - 0
Pharma

Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting

Life Sciences Times - 0
1...141516...62Page 15 of 62

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: [email protected]

FOLLOW US

© Newspaper WordPress Theme by TagDiv